Table 3.
Group-3: Association not directly related to the disease causative mutation
|
Genetic syndrome
|
Inheritance
|
Gene
|
Ref.
|
Number of AIH cases
|
Sex
|
Age at diagnosis
|
Nucleotide variant
|
Protein variant
|
Outcome
|
| NS | AD | PTPN11 | Quaio et al[38], 2012 | 1 | M | 19 yr | c.[836A>G];[=] | p.[(Y279C)];[(=)] | Alive |
| Loddo et al[5], 2015 | 1 | F | 6 yr | c.[923A>G];[=] | p.[(N308S)];[(=)] | Alive | |||
| WD | AR | ATP7B | Ganesh et al[40], 2017 | 1 | M | 6 yr | c.[2906G>A];[2906G>A] | p.[(R969Q)];[(R969Q)] | Alive |
| Santos et al[41], 2019 | 1 | F | 25 yr | N.R. | N.R. | Alive | |||
| H syndrome | AR | SLC29A3 | Bloom et al[42], 2017 | 1 | M | 17 mo | c.[1087C>T];[1087C>T] | p.[(R363W)];[(R363W)] | Alive |
| FHL5 | AR | STXBP2 | Esmaeilzadeh et al[43], 2015 | 1 | M | 7 yr | c.[1247-1G>C];[1247-1G>C] | p.[(?)];[(?)] | Death |
| TSC | AD | TSC1 | Di Marco et al[44], 2017 | 1 | F | 47 yr | c.[682C>T];[=] | p.[(R228*)];[(=)] | Alive |
| SCD | AR | HBB | Jitraruch et al[45], 2017 | 7 | F; M; M; F; F; F; F | 5 yr; 16 yr; 13 yr; 13 yr; 8 yr; 8 yr; 3 yr | c.[20A>T];[20A>T] | p.[(E7V)];[(E7V)] | Alive; Alive; Death; Alive; Alive; Alive; Death |
| Zellos et al[46], 2010 | 1 | F | 25 yr | c.[20A>T];[20A>T] | p.[(E7V)];[(E7V)] | Death | |||
| Hurtova et al[47], 2011 | 1 | F | 54 yr | c.[20A>T];[20A>T] | p.[(E7V)];[(E7V)] | Death | |||
| GD | AR | GBA | Ayto et al[48], 2010 | 1 | F | 51 yr | c.[1226A>G];[115+1G>A] | p.[(N409S)];[(?)] | Death |
| PLCA | AD | - | González-Moreno et al[50], 2015 | 1 | M | 36 yr | NR | NR | Alive |
| Yan and Jin[49] | 1 | F | 50 yr | NR | N.R. | Alive | |||
| PFIC3 | AR | ABCB4 | Oliveira et al[51], 2017 | 1 | M | 22 yr | c.[874A>T];[3680T>C] | p.[(K292*)];[(I1227T)] | Alive |
AIH: Autoimmune hepatitis; AD: Autosomal dominant; AR: Autosomal recessive; F: Female; M: Male; NR: Not reported; NS: Noonan syndrome; WD: Wilson disease; FHL: Familial hemophagocytic lymphohistiocytosis; TSC: Tuberous syndrome; SCD: Sickle cell disease; GD: Gaucher disease; PLCA: Primary cutaneous amyloidosis; PFIC3: Progressive familiar intrahepatic cholestasis type 3.